Original Research
Published on 31 Oct 2022
Serum cytokines predict efficacy and toxicity, but are not useful for disease monitoring in lung cancer treated with PD-(L)1 inhibitors
in Cancer Immunity and Immunotherapy
- 2,780 views
- 11 citations
Original Research
Published on 31 Oct 2022
in Cancer Immunity and Immunotherapy
Original Research
Published on 25 Oct 2022
in Cancer Immunity and Immunotherapy
Original Research
Published on 25 Oct 2022
in Cancer Immunity and Immunotherapy
Review
Published on 25 Oct 2022
in Cancer Immunity and Immunotherapy
Original Research
Published on 25 Oct 2022
in Cancer Immunity and Immunotherapy
Original Research
Published on 24 Oct 2022
in Cancer Immunity and Immunotherapy
Original Research
Published on 24 Oct 2022
in Cancer Immunity and Immunotherapy
Original Research
Published on 21 Oct 2022
in Cancer Immunity and Immunotherapy
Review
Published on 21 Oct 2022
in Cancer Immunity and Immunotherapy
Original Research
Published on 20 Oct 2022
in Cancer Immunity and Immunotherapy
Original Research
Published on 20 Oct 2022
in Cancer Immunity and Immunotherapy
Editorial
Published on 18 Oct 2022
in Cancer Immunity and Immunotherapy
Systematic Review
Published on 18 Oct 2022
in Cancer Immunity and Immunotherapy
Perspective
Published on 18 Oct 2022
in Cancer Immunity and Immunotherapy
Review
Published on 13 Oct 2022
in Cancer Immunity and Immunotherapy
Mini Review
Published on 13 Oct 2022
in Cancer Immunity and Immunotherapy